XML 33 R24.htm IDEA: XBRL DOCUMENT
v3.23.1

Earnings Per Share | 3 Months Ended
--- | ---
Mar. 31, 2023
Earnings Per Share |
Earnings Per Share | Note 14 Earnings Per Share ​ The Company calculates earnings per share under the two-class method, as certain non-vested share awards contain non-forfeitable rights to dividends. As such, these awards are considered securities that participate in the earnings of the Company. Non-vested shares are discussed further in note 12. ​ The Company had 37,641,381 and 30,008,781 shares of Class A common stock outstanding as of March 31, 2023 and 2022, respectively, exclusive of issued non-vested restricted shares. Certain stock options and non-vested restricted shares are potentially dilutive securities, but are not included in the calculation of diluted earnings per share because to do so would have been anti-dilutive for the three months ended March 31, 2023 and 2022. ​ The following table illustrates the computation of basic and diluted earnings per share for the three months ended March 31, 2023 and 2022: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the three months ended
​ |  | March 31, 2023 |  | March 31, 2022
Net income | ​ | $ | 40,283 | ​ | $ | 18,352
Less: income allocated to participating securities | ​ |  | (42) | ​ |  | (33)
Income allocated to common shareholders | ​ | $ | 40,241 | ​ | $ | 18,319
Weighted average shares outstanding for basic earnings per common share | ​ |  | 37,785,488 | ​ |  | 30,120,195
Dilutive effect of equity awards | ​ |  | 289,485 | ​ |  | 359,066
Weighted average shares outstanding for diluted earnings per common share | ​ |  | 38,074,973 | ​ |  | 30,479,261
Basic earnings per share | ​ | $ | 1.06 | ​ | $ | 0.61
Diluted earnings per share | ​ | ​ | 1.06 | ​ | ​ | 0.60
​ The Company had 715,188 and 691,083 outstanding stock options to purchase common stock at weighted average exercise prices of $29.82 and $28.18 per share at March 31, 2023 and 2022, respectively, which have time-vesting criteria, and as such, any dilution is derived only for the time frame in which the vesting criteria had been met and where the inclusion of those stock options is dilutive. The Company had 296,853 and 250,449 unvested restricted shares and performance stock units issued as of March 31, 2023 and 2022, respectively, which have performance, market and/or time-vesting criteria, and as such, any dilution is derived only for the time frame in which the vesting criteria had been met and where the inclusion of those restricted shares and units is dilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI https://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration